113 related articles for article (PubMed ID: 12045337)
1. Release from or through a wax matrix system. III. Basic properties of release through the wax matrix layer.
Yonezawa Y; Ishida S; Suzuki S; Sunada H
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):814-7. PubMed ID: 12045337
[TBL] [Abstract][Full Text] [Related]
2. Release from or through a wax matrix system. IV. Generalized expression of the release process for a reservoir device tablet.
Yonezawa Y; Ishida S; Suzuki S; Sunada H
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1219-22. PubMed ID: 12237539
[TBL] [Abstract][Full Text] [Related]
3. Release from or through a wax matrix system. II. Basic properties of release from or through the wax matrix layer.
Yonezawa Y; Ishida S; Suzuki S; Sunada H
Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):220-4. PubMed ID: 11848213
[TBL] [Abstract][Full Text] [Related]
4. Release from or through a wax matrix system. I. Basic release properties of the wax matrix system.
Yonezawa Y; Ishida S; Sunada H
Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1448-51. PubMed ID: 11724236
[TBL] [Abstract][Full Text] [Related]
5. Release from or through a wax matrix system. VI. Analysis and prediction of the entire release process of the wax matrix tablet.
Yonezawa Y; Ishida S; Sunada H
Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):915-8. PubMed ID: 16079519
[TBL] [Abstract][Full Text] [Related]
6. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
Peerapattana J; Otsuka K; Otsuka M
Biomed Mater Eng; 2004; 14(3):293-301. PubMed ID: 15299241
[TBL] [Abstract][Full Text] [Related]
7. Release from or through a wax matrix system. V. Applicability of the square-root time law equation for release from a wax matrix tablet.
Yonezawa Y; Ishida S; Sunada H
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):904-8. PubMed ID: 12913226
[TBL] [Abstract][Full Text] [Related]
8. Influence of internal structure on kinetics of drug release from wax matrix tablets.
Ishino R; Yoshino H; Hirikawa Y; Noda K
Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3440-5. PubMed ID: 2092942
[TBL] [Abstract][Full Text] [Related]
9. Melt granulation and heat treatment for wax matrix-controlled drug release.
Zhang YE; Schwartz JB
Drug Dev Ind Pharm; 2003 Feb; 29(2):131-8. PubMed ID: 12648009
[TBL] [Abstract][Full Text] [Related]
10. Effect of cogrinding time on the release of pentoxifylline from waxy matrix tablets.
Otsuka M; Matsuda Y
J Pharm Sci; 1994 Jul; 83(7):956-61. PubMed ID: 7965674
[TBL] [Abstract][Full Text] [Related]
11. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
Phaechamud T; Choncheewa CE
AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
[TBL] [Abstract][Full Text] [Related]
12. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
[TBL] [Abstract][Full Text] [Related]
13. Effect of diluents on tablet integrity and controlled drug release.
Zhang YE; Schwartz JB
Drug Dev Ind Pharm; 2000 Jul; 26(7):761-5. PubMed ID: 10872095
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
15. Multi-unit dosage formulations of theophylline for controlled release applications.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
17. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
Perez MA; Ghaly ES; Marti A
P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
[TBL] [Abstract][Full Text] [Related]
18. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
Cheboyina S; Wyandt CM
Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
[TBL] [Abstract][Full Text] [Related]
19. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
[TBL] [Abstract][Full Text] [Related]
20. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
